This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Bronchoscopic Closure of Bronchopleural Fistulas With Occlutech Figulla ASD N Occluder Device

This study has been completed.
Sponsor:
Collaborators:
InCor Heart Institute
Occlutech International AB
Information provided by (Responsible Party):
Miguel L. Tedde, University of Sao Paulo
ClinicalTrials.gov Identifier:
NCT01153074
First received: June 28, 2010
Last updated: May 23, 2017
Last verified: May 2017
  Purpose
The purpose of this study is to evaluate the feasibility of closing bronchopleural fistulas with devices originally developed for correction of cardiac septal defects deployed through bronchoscopic procedures.

Condition Intervention
Bronchopleural Fistula Device: Closure of bronchopleural fistula with Occlutech Figulla

Study Type: Interventional
Study Design: Intervention Model: Sequential Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Bronchoscopic Closure of Bronchopleural Fistulas With Occlutech Figulla ASD N Occluder Device

Resource links provided by NLM:


Further study details as provided by Miguel L. Tedde, University of Sao Paulo:

Primary Outcome Measures:
  • Closure of tracheobronchial fistulas with the Occlutech Figulla ASD N occluder [ Time Frame: 1 year ]

    The closure of the fistulas will be bronchoscopically observed at regular intervals: one week, three weeks, two months and six months.

    At the third months post intervention, a thorax CT scan will ascertain the correct position and stability of the device.



Enrollment: 8
Study Start Date: June 2010
Study Completion Date: October 2016
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Occluder
The patients with bronchopleural fistulas treated with bronchoscopic deployment of the cardiac septal defects occluder.
Device: Closure of bronchopleural fistula with Occlutech Figulla
Patients with bronchopleural fistulas will be submitted to a bronchoscopic procedure to deploy the cardiac septal defect occluder in the fistula traject.
Other Name: Bronchoscopic bronchopleural fistula closure with occluders

  Eligibility

Ages Eligible for Study:   14 Years and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients over 14 years old
  • Bronchopleural fistulas

Exclusion Criteria:

  • Clinical conditions increasing surgical risk (hemodynamic instability, respiratory distress)
  • Immunosuppressed patients
  • Acute intense inflammatory process in fistula edge
  • Suppurative pleural cavity infection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01153074

Locations
Brazil
Heart Institute (InCor) Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo
Sao Paulo, Brazil, 05403-900
Hospital das Clinicas, Faculdade de Medicina, Universidade de Sao Paulo
Sao Paulo, Brazil
Sponsors and Collaborators
University of Sao Paulo
InCor Heart Institute
Occlutech International AB
Investigators
Principal Investigator: Miguel L. Tedde, MD, PhD Heart Institute (InCor) HC of the Sao Paulo University School